Table 3.
Barriers to ADR reporting experienced by profession.
| Reasons | Profession of Respondents, N (%) | p-Value a | |||
|---|---|---|---|---|---|
| Physician (n = 22) |
Pharmacist (n = 27) |
Nurse (n = 106) |
Total (n = 155) |
||
| Well-known ADRs | 6 (27.3) | 6 (22.2) | 23 (21.7) | 35 (22.6) | 0.849 |
| Not serious ADRs | 5 (22.7) | 8 (29.6) | 16 (15.1) | 29 (18.7) | 0.196 |
| Uncertainty of the causal relationship between drug and reactions | 17 (77.3) | 18 (66.7) | 58 (54.7) | 93 (60.0) | 0.107 |
| Not understanding the ADR monitoring process | 9 (40.9) | 3 (11.1) | 18 (17.0) | 30 (19.4) | 0.017 * |
| ADR reporting forms unnavailable | 4 (18.2) | 2 (7.4) | 24 (22.6) | 30 (19.4) | 0.200 |
| ADR reporting forms too complicated | 3 (13.6) | 4 (14.8) | 5 (4.7) | 12 (7.7) | 0.078 b |
| Inadequate time for ADR reporting | 6 (27.3) | 11 (40.7) | 11 (10.4) | 28 (18.1) | 0.001 b,* |
| Lack of cooperation between healthcare teams | 2 (9.1) | 3 (11.1) | 7 (6.6) | 12 (7.7) | 0.581 b |
| Staff shortage | 3 (13.6) | 7 (25.9) | 8 (7.5) | 18 (11.6) | 0.022 b,* |
| Lack of support from leaders | 2 (9.1) | 0 (0.0) | 4 (3.8) | 6 (3.9) | 0.195 b |
| Lack of technology to monitor ADRs | 4 (18.2) | 1 (3.7) | 5 (4.7) | 10 (6.5) | 0.055 b |
a Pearson’s chi-squared test; b Fisher’s exact test; * the level of significant different < 0.05.